CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Icagen, Inc.  (ICGND)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

ICGND's Revenue Year on Year Growth by Quarter and Year

Icagen,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
ICGND Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 5.63 1.00 0.13 0.00
III Quarter September 4.31 0.47 0.07 0.00
II Quarter June 1.16 0.10 0.08 0.00
I Quarter March 0.90 0.03 0.25 0.00
FY   12.00 1.60 0.53 -

Financial Statements
Icagen,'s forth quarter 2016 Revenue $ 5.63 millions ICGND's Income Statement
Icagen,'s forth quarter 2015 Revenue $ 1.00 millions Quarterly ICGND's Income Statement
ICGND's Growth by Division See ICGND's Growth by Segment

ICGND Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 462.9 % 669.23 % - -
III Quarter September 817.02 % 571.43 % - -
II Quarter June 1060 % 25 % - -
I Quarter March 2900 % -88 % - -
FY   649.93 % 201.89 % - -



ICGND Revenue Growth Comment
Icagen, Inc. reported Revenue surge of 462.9% year on year in the forth quarter, to $ 5.63 millions, this is lower than Icagen, Inc.'s recent average Revenue surge of 796.4%.

Looking into forth quarter results within Medical Laboratories industry 3 other companies have achieved higher Revenue growth. While Icagen, Inc.' s Revenue doubling of 462.9% ranks overall at the positon no. 79 in the forth quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #4
Healthcare Sector #19
S&P 500 #79
Revenue Y/Y Growth Statistics
High Average Low
2838.92 % 796.4 % -87.94 %
(Mar 31 2016)   (Mar 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ICGND's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ICGND's Competitors
Revenue Growth for Icagen,'s Suppliers
Revenue Growth for ICGND's Customers

You may also want to know
ICGND's Annual Growth Rates ICGND's Profitability Ratios ICGND's Asset Turnover Ratio ICGND's Dividend Growth
ICGND's Roe ICGND's Valuation Ratios ICGND's Financial Strength Ratios ICGND's Dividend Payout Ratio
ICGND's Roa ICGND's Inventory Turnover Ratio ICGND's Growth Rates ICGND's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Exact Sciences Corp  589.15 %$ 589.154 millions
Hci Viocare  554.40 %$ 554.402 millions
Sophiris Bio Inc.  550.00 %$ 550.000 millions
Biosig Technologies, Inc.  507.28 %$ 507.282 millions
Icagen, Inc.  463.97 %$ 463.975 millions
Juno Therapeutics, Inc.  409.47 %$ 409.465 millions
Gtx Corp  374.22 %$ 374.216 millions
China Senior Living Industry International Holding  358.34 %$ 358.342 millions
Eagle Pharmaceuticals, Inc.  346.31 %$ 346.315 millions
Nuo Therapeutics, Inc.  336.84 %$ 336.844 millions
Sarepta Therapeutics, Inc.  332.64 %$ 332.642 millions
Positiveid Corp  280.62 %$ 280.620 millions
Acelrx Pharmaceuticals Inc  271.97 %$ 271.965 millions
Agios Pharmaceuticals Inc  264.23 %$ 264.233 millions
Aradigm Corp  257.14 %$ 257.143 millions
Organovo Holdings, Inc.  250.91 %$ 250.915 millions
Cord Blood America, Inc.  250.14 %$ 250.144 millions
Neuralstem, Inc.  249.84 %$ 249.840 millions
Cytokinetics Inc  239.62 %$ 239.623 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com